Product Code: ETC13162227 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Psoriatic Arthritis Treatment Market was valued at USD 10 Billion in 2024 and is expected to reach USD 15 Billion by 2031, growing at a compound annual growth rate of 6.20% during the forecast period (2025-2031).
The Global Psoriatic Arthritis Treatment Market is experiencing significant growth due to the rising prevalence of psoriatic arthritis, an autoimmune disease characterized by joint pain and skin inflammation. The market is driven by increasing awareness, improved diagnostic techniques, and the introduction of advanced biologic therapies. Biologic drugs such as TNF inhibitors, IL-12/23 inhibitors, and JAK inhibitors are gaining traction in the market for their efficacy in managing symptoms and slowing disease progression. Additionally, the adoption of combination therapies and personalized treatment approaches are expected to further drive market growth. North America currently dominates the market, followed by Europe and Asia Pacific, with key players investing in research and development to bring innovative treatments to the market. However, challenges such as high treatment costs and side effects may hinder market growth in the coming years.
The Global Psoriatic Arthritis Treatment Market is witnessing significant growth due to the increasing prevalence of psoriatic arthritis worldwide. One of the key trends in the market is the rising adoption of biologic therapies, which offer targeted treatment options with improved efficacy and safety profiles compared to traditional therapies. Additionally, the development of novel treatment approaches such as small molecule inhibitors and personalized medicine is creating new opportunities for market players. The market is also benefiting from advancements in diagnostic techniques and a growing focus on early detection and intervention. With the increasing research and development activities in the field, there is a promising outlook for innovative treatment options and improved patient outcomes in the Global Psoriatic Arthritis Treatment Market.
The Global Psoriatic Arthritis Treatment Market faces several challenges, including limited awareness about the condition among both patients and healthcare providers, leading to underdiagnosis and undertreatment. Additionally, the complex nature of psoriatic arthritis, which involves both joint inflammation and skin symptoms, can make accurate diagnosis and effective treatment challenging. The high cost of some advanced treatment options, such as biologic drugs, can also be a barrier for patients seeking optimal care. Furthermore, the lack of standardized guidelines for the management of psoriatic arthritis and the varying response rates to different treatments among patients present further challenges in delivering personalized and effective care in this market.
The global psoriatic arthritis treatment market is driven by several key factors, including the increasing prevalence of psoriatic arthritis worldwide, growing awareness about the condition among healthcare professionals and patients, advancements in treatment options such as biologic therapies and targeted therapies, and rising investment in research and development activities focused on developing innovative treatment solutions. Additionally, the expanding geriatric population, changing lifestyle patterns leading to higher incidence of psoriatic arthritis, and improving healthcare infrastructure in emerging economies are also contributing to the growth of the market. The market is further propelled by the rising demand for personalized medicine and the shift towards combination therapies for better disease management and improved patient outcomes.
Government policies related to the Global Psoriatic Arthritis Treatment Market primarily focus on ensuring access to affordable and effective treatments for patients. Regulatory bodies, such as the FDA in the United States and the EMA in Europe, play a key role in approving new therapies and ensuring their safety and efficacy. Government initiatives also aim to promote research and development in the field of psoriatic arthritis treatment, providing funding and support to pharmaceutical companies and academic institutions. Additionally, healthcare reimbursement policies and insurance coverage schemes are designed to facilitate patient access to necessary medications and therapies. Overall, government policies strive to foster innovation, improve patient outcomes, and address the unmet medical needs of individuals living with psoriatic arthritis.
The Global Psoriatic Arthritis Treatment Market is expected to witness significant growth in the coming years due to the increasing prevalence of psoriatic arthritis worldwide. The market is likely to be driven by advancements in treatment options, including biologic therapies and targeted therapies, which offer more effective and personalized treatment approaches. Moreover, the rising awareness about the condition among healthcare professionals and patients, along with the expanding healthcare infrastructure in emerging economies, will further propel market growth. However, challenges such as high treatment costs and stringent regulatory requirements may hinder market expansion to some extent. Overall, the Global Psoriatic Arthritis Treatment Market is projected to experience steady growth, with opportunities for market players to innovate and develop novel therapies to address unmet medical needs in this space.
In the Global Psoriatic Arthritis Treatment Market, North America holds a significant share due to high prevalence of psoriatic arthritis and strong healthcare infrastructure. Europe follows closely behind, driven by increasing awareness about the condition and availability of advanced treatment options. In Asia, the market is rapidly growing with rising cases of psoriatic arthritis and improving access to healthcare. The Middle East and Africa region is witnessing steady growth, fueled by expanding healthcare facilities and increasing investments in research and development. Latin America shows promising potential for market growth, driven by improving healthcare infrastructure and growing awareness about psoriatic arthritis treatment options. Overall, the global psoriatic arthritis treatment market is expected to continue expanding across all regions due to increasing prevalence of the condition and advancements in treatment options.
Global Psoriatic Arthritis Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Psoriatic Arthritis Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Psoriatic Arthritis Treatment Market - Industry Life Cycle |
3.4 Global Psoriatic Arthritis Treatment Market - Porter's Five Forces |
3.5 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.8 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Global Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Psoriatic Arthritis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Psoriatic Arthritis Treatment Market Trends |
6 Global Psoriatic Arthritis Treatment Market, 2021 - 2031 |
6.1 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2021 - 2031 |
6.1.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Disease-modifying Antirheumatic Drugs (DMARDs), 2021 - 2031 |
6.1.4 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Oligoarticular, 2021 - 2031 |
6.2.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Polyarticular, 2021 - 2031 |
6.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.3.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.4 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.5 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.6 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 Global Psoriatic Arthritis Treatment Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Psoriatic Arthritis Treatment Market, Overview & Analysis |
7.1 North America Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
7.5 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8 North America Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.4 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
8.5 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.8 Latin America (LATAM) Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Psoriatic Arthritis Treatment Market, Overview & Analysis |
9.1 Asia Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.4 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
9.5 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.8 Asia Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Psoriatic Arthritis Treatment Market, Overview & Analysis |
10.1 Africa Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.4 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
10.5 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.8 Africa Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Psoriatic Arthritis Treatment Market, Overview & Analysis |
11.1 Europe Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.4 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
11.5 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.8 Europe Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Psoriatic Arthritis Treatment Market, Overview & Analysis |
12.1 Middle East Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Psoriatic Arthritis Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.4 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Types, 2021 - 2031 |
12.5 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.8 Middle East Psoriatic Arthritis Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Psoriatic Arthritis Treatment Market Key Performance Indicators |
14 Global Psoriatic Arthritis Treatment Market - Export/Import By Countries Assessment |
15 Global Psoriatic Arthritis Treatment Market - Opportunity Assessment |
15.1 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.3 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
15.4 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.7 Global Psoriatic Arthritis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Psoriatic Arthritis Treatment Market - Competitive Landscape |
16.1 Global Psoriatic Arthritis Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Psoriatic Arthritis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |